论文部分内容阅读
目的:分析用硫酸镁治疗妊娠高血压综合征的临床疗效。方法:对2011年1月至2013年12月我院收治的48例妊娠高血压综合征患者的临床资料进行回顾性分析,探讨为其使用硫酸镁进行治疗的临床效果。结果:本组患者在进行治疗后,有25例患者治疗显效,有20例患者治疗有效,有3例患者治疗无效,其治疗的总有效率为93.75%(45/48)。在进行治疗前,本组患者的收缩压、舒张压分别为(163.2±11.2)mmHg、(119.7±11.4)mmHg。在进行治疗后,本组患者的收缩压、舒张压分别为(124.3±5.7)mmHg、(88.1±4.9)mmHg,与治疗前相比血压水平明显下降,差异显著(P<0.05),有统计学意义。在进行治疗后,本组患者的HCT、Hb、PLT、PDW、MPV等血常规指标均得到明显的改善,与治疗前相比差异显著(P<0.05),有统计学意义。本组患者发生产后并发症的几率为8.33%(4/48)。结论:应用硫酸镁治疗妊娠高血压综合征安全有效,值得在临床上推广应用。
Objective: To analyze the clinical efficacy of magnesium sulfate in the treatment of pregnancy-induced hypertension syndrome. Methods: The clinical data of 48 patients with pregnancy-induced hypertension syndrome treated in our hospital from January 2011 to December 2013 were analyzed retrospectively to investigate the clinical effect of magnesium sulfate for their treatment. Results: After treatment, 25 patients were treated effectively, 20 patients were effective, 3 patients were ineffective, and the total effective rate was 93.75% (45/48). Before treatment, systolic and diastolic blood pressure were (163.2 ± 11.2) mmHg and (119.7 ± 11.4) mmHg, respectively. After treatment, systolic blood pressure and diastolic blood pressure were (124.3 ± 5.7) mmHg and (88.1 ± 4.9) mmHg, respectively, which were significantly lower than those before treatment (P <0.05) Significance of learning. After treatment, the blood parameters such as HCT, Hb, PLT, PDW and MPV in this group were significantly improved, which were significantly different from those before treatment (P <0.05). The incidence of postpartum complications in this group of patients was 8.33% (4/48). Conclusion: The application of magnesium sulfate in the treatment of pregnancy-induced hypertension is safe and effective, which is worth popularizing in clinic.